Blue Jet Healthcare Share Price | Blue Jet Healthcare Stock Screener
BLUEJET
Pharmaceuticals
Share Price NSE
₹470.25
▼
-29.30 (-5.87%)
Share Price BSE
₹470.45
▼
-28.35 (-5.68%)
As of May 27, 2026, the Blue Jet Healthcare share price (NSE: BLUEJET) is ₹470.25 on NSE and ₹470.45 on BSE, down 5.87% from the previous close, with shares trading between ₹468.20 and ₹496.85, and a 52-week range of ₹327.25–₹1,010.20.
Check BLUEJET 52-week high low for the annual price range and momentum.
Use the Blue Jet Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Blue Jet Healthcare Market Cap
₹8,665.47 Cr.
BLUEJET P/E Ratio (TTM)
-
Blue Jet Healthcare P/B Ratio
6.15
EPS (TTM)
₹1396.27
Dividend Yield
0.25%
Debt to Equity
0.24
BLUEJET 52 Week High
₹1010.20
Blue Jet Healthcare 52 Week Low
₹327.25
Operating Margin
-
Profit Margin
-
BLUEJET Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹536.00
Total Equity
₹340.00
Blue Jet Healthcare Share Price Chart
Screen Blue Jet Healthcare share price with an interactive chart. Analyse BLUEJET price trends and volatility across different timeframes.
Blue Jet Healthcare Company Profile - Fundamental Screener
Screen Blue Jet Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BLUEJET shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0KBH01020
Blue Jet Healthcare Balance Sheet Screener
Screen BLUEJET balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2021 | 2020 |
|---|---|---|
| Assets | ||
| Total Assets | 536 | 375 |
| Current Assets | 390 | 249 |
| Fixed Assets | 139 | 107 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 33 | 39 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 340 | 203 |
| Share Capital | 10 | 1 |
| Reserves & Surplus | 320 | 182 |
Blue Jet Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Blue Jet Healthcare income statement and profit fundamentals.
Analyze BLUEJET quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Blue Jet Healthcare share price evaluation.
| Item | None-None | 2021-March | 2020-March |
|---|---|---|---|
| Revenue | 0 | 508 | 544 |
| Expenses | 0 | 293 | 325 |
| EBITDA | 0 | 215 | 220 |
| Operating Profit % | 0.00% | 41.00% | 40.00% |
| Depreciation | 0 | 20 | 18 |
| Interest | 0 | 5 | 7 |
| Profit Before Tax | 0 | 185 | 194 |
| Tax | 0 | 49 | 49 |
| Net Profit | 0 | 136 | 145 |
| EPS | 0.00 | 1396.27 | 1462.60 |
Blue Jet Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen BLUEJET cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2021-March | 2020-March |
|---|---|---|
| Operating Activities | 129 | 123 |
| Investing Activities | -51 | -45 |
| Financing Activities | -28 | -73 |
| Net Cash Flow | 51 | 5 |
Blue Jet Healthcare Shareholding Pattern Screener
See Blue Jet Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Blue Jet Healthcare promoter holding and ownership changes for BLUEJET on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 79.81% | 86.00% | 86.00% | 79.81% | 79.81% | 86.00% | 86.00% | 86.00% |
| FII Holding | 0.88% | 2.29% | 1.97% | 1.82% | 1.14% | 2.01% | 2.02% | 2.18% |
| DII Holding | 4.51% | 1.33% | 0.94% | 3.63% | 4.65% | 3.03% | 2.14% | 1.74% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.60% | 7.28% | 8.03% | 9.78% | 9.91% | 5.36% | 5.79% | 5.90% |
| Other Holding | 4.20% | 3.10% | 3.05% | 4.95% | 4.50% | 3.60% | 4.04% | 4.17% |
| Shareholder Count | 79,199 | 54,581 | 70,772 | 80,117 | 80,187 | 48,625 | 42,882 | 41,933 |
Blue Jet Healthcare Share Dividend Screener - Share Yield Analysis
Check Blue Jet Healthcare dividend history with payout and yield data.
View Blue Jet Healthcare dividend details including ex-dates and amounts for BLUEJET stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.20 | 0.37% |
| 2024-March | ₹1.00 | 0.11% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Blue Jet Healthcare Stock Index Membership
See which indices include Blue Jet Healthcare stock.
Check BLUEJET index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Blue Jet Healthcare Market Events Screener - Corporate Actions
Get Blue Jet Healthcare corporate actions including splits, bonuses, and buybacks.
Check Blue Jet Healthcare stock events that may affect BLUEJET share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.20 /share | -11.15% | ||
| Annual General Meeting | NA | 3.98% | ||
| Dividend | ₹ 1.00 /share | 40.27% | ||
| Annual General Meeting | NA | -13.73% | ||
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 4.75% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 8.58% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 5.67% |
| 2025-07-22 | 2025-07-22 | Quarterly Result Announcement | NA | 5.40% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | 6.36% |
| 2025-01-29 | 2025-01-29 | Quarterly Result Announcement | NA | -1.39% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | 1.40% |
Blue Jet Healthcare Competitors Screener - Peer Comparison
Screen BLUEJET competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,670 | 40.42 | 58,220 | 6.38% | 11,565 | 54.06 |
| Divis Laboratories | 179,271 | 73.73 | 10,560 | 8.73% | 2,520 | 57.07 |
| Torrent Pharmaceuticals | 150,679 | 66.80 | 13,753 | 19.18% | 2,028 | 56.43 |
| Cipla | 114,503 | 29.26 | 27,712 | -2.46% | 3,783 | 64.74 |
| Dr Reddys Laboratories | 110,832 | 26.24 | 33,593 | -0.44% | 3,998 | 56.54 |
| Zydus Life Science | 108,578 | 20.40 | 26,720 | 13.65% | 5,242 | 74.62 |
| Lupin | 103,566 | 19.46 | 27,488 | 19.98% | 5,345 | 45.18 |
| Mankind Pharma | 100,047 | 52.84 | 14,278 | 12.03% | 1,750 | 55.67 |
| Aurobindo Pharma | 84,867 | 24.29 | 33,385 | 3.21% | 3,376 | 52.40 |
| Laurus Labs | 74,171 | 81.46 | 6,813 | 21.03% | 884 | 80.00 |
Blue Jet Healthcare Company Announcements - News Screener
Screen BLUEJET latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Notice Of Extra-Ordinary General Meeting Of Blue Jet Healthcare Limited | - | |
| Announcement under Regulation 30 (LODR)-Newspaper Publication | - | |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-28 | Corporate Action-Board approves Dividend | - |
| 2026-05-28 | Financial Results For March 31 2026 | - |
| 2026-05-28 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-22 | Board Meeting Intimation for As Per Attached Pdf | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-19 | Company Update | - |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-13 | Outcome Of Board Meeting | - |